Nextech3D.ai Announces Definitive Agreement to Acquire 100% of ARway, Streamlining Operations Artificial Intelligence Investing
PharmaTher Closes Sale of Ketamine ANDA, Sharpening Focus on Long-Acting Injectable Ketamine Franchise Life Science Investing
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc Life Science Investing
PainReform Commences Development for OcuRing-K Phase II Trial, LayerBio's Drop-Less Sustained-Release Ocular Therapy Life Science Investing
Incyte and Winnie Harlow Join Forces to Share Her Personal Vitiligo Story and Spark Conversation and Understanding Life Science Investing
NRx Pharmaceuticals Announces US Food and Drug Administration Receipt of ANDA for KETAFREE, a Preservative-Free IV Ketamine Life Science Investing
Harmony Biosciences to Present New Open-Label Extension Data from Phase 3 ARGUS Trial at the 2025 American Epilepsy Society Annual Meeting Life Science Investing
Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology Life Science Investing
Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia Life Science Investing
Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company Life Science Investing
